AU2002365104A8 - Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof - Google Patents

Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof

Info

Publication number
AU2002365104A8
AU2002365104A8 AU2002365104A AU2002365104A AU2002365104A8 AU 2002365104 A8 AU2002365104 A8 AU 2002365104A8 AU 2002365104 A AU2002365104 A AU 2002365104A AU 2002365104 A AU2002365104 A AU 2002365104A AU 2002365104 A8 AU2002365104 A8 AU 2002365104A8
Authority
AU
Australia
Prior art keywords
diagnosis
breast cancer
cancer diseases
associated peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365104A
Other versions
AU2002365104A1 (en
Inventor
Markus Kellemann
Hans Kreipe
Harald Tammen
Norbert Lamping
Rudiger Hess
Richard Lilischkis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovision AG
Original Assignee
Biovision AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovision AG filed Critical Biovision AG
Publication of AU2002365104A8 publication Critical patent/AU2002365104A8/en
Publication of AU2002365104A1 publication Critical patent/AU2002365104A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002365104A 2001-12-21 2002-12-20 Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof Abandoned AU2002365104A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10163747 2001-12-21
DE10163747.0 2001-12-21
PCT/DE2002/004708 WO2003056341A2 (en) 2001-12-21 2002-12-20 Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof

Publications (2)

Publication Number Publication Date
AU2002365104A8 true AU2002365104A8 (en) 2003-07-15
AU2002365104A1 AU2002365104A1 (en) 2003-07-15

Family

ID=7710714

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365104A Abandoned AU2002365104A1 (en) 2001-12-21 2002-12-20 Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof

Country Status (3)

Country Link
AU (1) AU2002365104A1 (en)
DE (1) DE10296200D2 (en)
WO (1) WO2003056341A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013013A2 (en) * 2004-08-04 2006-02-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb)
US8980269B2 (en) 2009-07-14 2015-03-17 Temple University Of The Commonwealth System Of Higher Education G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker
EP2454280A2 (en) 2009-07-14 2012-05-23 Temple University Of The Commonwealth System Of Higher Education Serum markers associated with early and other stages of breast cancer
US10627412B2 (en) 2010-03-17 2020-04-21 Kagoshima University Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
WO2002059377A2 (en) * 2001-01-24 2002-08-01 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer

Also Published As

Publication number Publication date
WO2003056341A3 (en) 2004-09-23
WO2003056341A2 (en) 2003-07-10
AU2002365104A1 (en) 2003-07-15
DE10296200D2 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
IL160998A0 (en) Human tissue factor antibodies
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU5947701A (en) Methods for identification, diagnosis, and treatment of breast cancer
AU2002348297A8 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
EP1420814A4 (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
EP1380840A4 (en) Method of diagnosing breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
AU2002365104A8 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
EP1250145A4 (en) C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer
AU2002364757A8 (en) Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
AU2002360815A8 (en) Human breast cancer biomarkers
AU2001280443A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
EP1438389A4 (en) Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
EP1426762A4 (en) Remedies for heart diseases
AU2003263036A8 (en) Span-xb gene and protein for the diagnosis and treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase